Analystreport

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $107.00 to $123.00. They now have a "buy

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report